CompletedPHASE2, PHASE3NCT00748423

Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study)

Studying Sickle cell disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
MAITRE Bernard, MD, PHD
Assistance Publique - Hôpitaux de Paris
Intervention
Nitric Oxide(drug)
Enrollment
100 enrolled
Eligibility
18 years · All sexes
Timeline
2008 – 2012

Study locations (1)

Collaborators

Mallinckrodt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00748423 on ClinicalTrials.gov

Other trials for Sickle cell disease

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell disease →

← Back to all trials